Melanoma Rates Decline Found in Younger Population

Melanoma Rates Decline Found in Younger Population

Cancer-News

2 months
3 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Up Next Autoplay
National Brain Tumor Society to Provide Funding for ONC201 Trial in EGFR-Independent High-Grade Gliomas
National Brain Tumor Society to Provide Funding for ONC201 Trial in EGFR-Independent High-Grade Gliomas
Category: Acute Lymphoblastic Leukemia
1 Views
alexvarney 1 hour
Supportive Care Video Series 2019 - Aromatase Inhibitor Induced Arthralgia (AI Induced Arthralgia)
Supportive Care Video Series 2019 - Aromatase Inhibitor Induced Arthralgia (AI Induced Arthralgia)
Category: Acute Lymphoblastic Leukemia
5 Views
cancergrace 3 weeks
Global Resource for Advancing Cancer Education Live Stream - Controversies in Managing NSCLC
Global Resource for Advancing Cancer Education Live Stream - Controversies in Managing NSCLC
Category: Acute Lymphoblastic Leukemia
5 Views
cancergrace 3 weeks
What is Immunotherapy with Dr. Narjust Duma (Spanish)
What is Immunotherapy with Dr. Narjust Duma (Spanish)
Category: Acute Lymphoblastic Leukemia
65 Views
cancergrace 3 weeks
Supportive Care 2019 - Androgen Deprivation Therapy (ADT) for Men with Prostate Cancer
Supportive Care 2019 - Androgen Deprivation Therapy (ADT) for Men with Prostate Cancer
Category: Acute Lymphoblastic Leukemia
9 Views
cancergrace 3 weeks
The Role of Immunotherapy in Metastatic Bladder Cancer
The Role of Immunotherapy in Metastatic Bladder Cancer
Category: Acute Lymphoblastic Leukemia
5 Views
cancergrace 3 weeks
What is Lung Cancer Screening (Spanish)
What is Lung Cancer Screening (Spanish)
Category: Acute Lymphoblastic Leukemia
3 Views
cancergrace 3 weeks
2019 Nobel Prize for Medicine Recipients recognized for Cancer Research  through study of von Hippel-Lindau (VHL) disease
2019 Nobel Prize for Medicine Recipients recognized for Cancer Research through study of von Hippel-Lindau (VHL) disease
Category: Acute Lymphoblastic Leukemia
6 Views
Cancer-News 1 month
INNATE PHARMA HIGHLIGHTS FDA-APPROVED LUMOXITI® AT ASH 2019
INNATE PHARMA HIGHLIGHTS FDA-APPROVED LUMOXITI® AT ASH 2019
Category: Acute Lymphoblastic Leukemia
25 Views
Cancer-News 1 month
Phase 1/2 AUGMENT-101 Trial @sloan_kettering
Phase 1/2 AUGMENT-101 Trial @sloan_kettering
Category: Acute Lymphoblastic Leukemia
14 Views
Memorial Sloan Kettering 2 months